UMass Cancer Center News

Proceeds from the UMass Cancer Walk, returning to Polar Park on Sunday, Sept. 27, support cancer research and clinical trials at UMass Chan.

PhD candidate Emily Blackburn, MPH, received a prestigious grant from the National Cancer Institute to research proliferating cell nuclear antigen, or PCNA.

UMass Chan clinical trial studies psychedelic medication for adjustment disorder related to serious illness

Novel mRNA treatment developed at UMass Chan Medical School eliminates pancreatic cancer tumors in 50 percent of treated mice.

UMass Chan Medical School researchers have received funding from the Massachusetts Life Sciences Center to advance research using artificial intelligence to improve early identification of pregnancy-induced hypertension and to establish a colorectal cancer biobank that will accelerate biomedical discoveries.

Classrooms and labs kept busy this summer at UMass Chan, hosting high school and college students participating in outreach programs.

AMP modified vaccine adjunct activates robust T cell response. 

UMass Chan Medical School faculty made new company pitches to leaders from nearly two dozen venture capital firms and other industry organizations.

Graduating PhD candidates in the Morningside Graduate School of Biomedical Sciences at UMass Chan Medical School were celebrated during an awards ceremony on May 28.

Marcus Ruscetti, PhD, received a $750,000 2026 Pershing Square Sohn Cancer Prize to advance his lab’s pancreatic cancer research.